Pasithea Therapeutics KTTAW Cash Flow Statement (2021-2026)

NASDAQ KTTAW
$0.00 0.00 (-36.36%)
As of: Sep 9, 2026 · 3:56 PM EDT
Reported Financials

Pasithea Therapeutics Quarterly Cash Flow Statement

Periods 22 quarters
Latest Jun 2026

Pasithea Therapeutics reported cash from operations of -$4.71M and free cash flow of -$4.71M for the quarter ended Jun 2026, down 21.7% year over year. This cash flow statement covers 22 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-1.53M0.63M-1.90M-3.13M-4.19M-8.53M-3.54M-3.76M-3.61M-5.11M-3.86M-3.87M-3.00M-3.18M-3.56M-3.72M-3.04M-10.11M-2.87M-5.27M
Share-based Compensation
0.01M0.60M1.00M1.00M0.16M15.36M15.36M15.36M0.07M0.30M0.77M0.19M0.12M0.16M0.15M0.15M0.09M1.69M7.55M
Cash from Discontinued Operations
-0.41M0.01M-0.63M-0.77M-0.18M-0.40M-0.01M-0.02M
Gains from Investment Securities
0.25M-2.59M-0.42M0.34M-0.98M0.05M-0.11M-0.04M0.06M-0.03M0.04M0.07M-0.00M-0.08M0.01M-0.05M
Cash from Operations
-0.55M-1.74M-2.15M-1.94M-4.62M-3.19M-3.20M-3.08M-3.24M-3.29M-4.32M-4.04M-3.12M-2.44M-3.06M-3.87M-2.89M-5.40M-4.79M-4.71M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
0.16M0.16M0.16M0.16M0.16M0.16M0.16M0.16M0.16M0.16M0.16M0.16M0.16M0.16M
Depreciation & Amortization (CF)Depreciation & Amortization
0.01M0.02M
Change in Working Capital
Change in Account Payables
-0.02M
Change in Accured Expenses
0.07M-0.08M0.03M0.03M0.41M0.28M-0.03M0.47M-0.05M0.68M-0.12M-1.04M-0.76M0.48M0.21M0.26M-0.24M-0.21M0.36M0.35M
Other Working Capital Changes
-0.05M0.56M-0.00M-963.00
Investing Activities
Capital Expenditures
0.01M0.00M0.01M0.01M0.09M0.05M0.00M-0.02M-36.00
Sales of Property, Plant and Equipment
0.03M0.05M
Acquisitions
0.02M2.25M
Divestments
-0.11M-0.43M-0.16M0.07M0.00M0.32M
Cash from Investing Activities
-0.01M-0.00M0.07M-0.03M-2.34M-0.05M0.02M0.05M0.05M
Financing Activities
Other financing activities
0.18M4.04M-2.20M53.41M
Debt Issuance and Repayment
Long-Term Debt Issuances
20.65M5.30M0.39M0.18M
Change in Capital Stock
Net Shares Issued and Repurchased
0.60M0.80M0.88M0.04M0.04M0.00M0.01M0.10M0.02M0.01M0.00M1.53M
Net Equity Issued and Repurchased
4.50M1.65M0.36M2.20M-2.14M0.36M
Misc.
Cash from Financing Activities
20.55M34.17M0.26M-0.13M-3.86M-0.02M1.47M5.74M-0.12M56.42M750.000.01M
Exchange Rate Effect
-0.00M-0.01M-0.00M-0.04M-0.08M0.14M-0.00M-317.00-0.00M0.00M-620.00-0.00M-0.03M0.03M0.01M465.000.03M-0.04M
Change in Cash
20.00M32.40M-2.68M-2.33M-5.52M-9.29M-3.17M-3.27M-7.06M-3.25M-4.32M-4.04M1.39M-2.44M-1.58M1.88M-2.99M51.04M-4.76M-4.74M
Free Cash Flow
-0.55M-1.76M-2.15M-1.94M-4.63M-3.28M-3.26M-3.08M-3.22M-3.29M-4.32M-4.04M-3.12M-2.44M-3.06M-3.87M-2.89M-5.40M-4.79M-4.71M
Net Cash Flow
20.01M32.41M-2.15M-1.87M-4.65M-5.53M-2.99M-3.19M-7.05M-3.24M-4.32M-4.04M-3.12M-2.47M-1.58M1.87M-3.01M51.02M-4.79M-4.70M